Beijing has approved more export licenses for the critical minerals and magnets in recent days, but supplies remain scarce ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

US President Donald Trump's tariff policy is proving ill-suited, and even counterproductive, for the US supply chain in ...

As a leader in its category, Sinotau is probably hoping to follow in the footsteps of Hengrui Pharmaceuticals (1276.HK; ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Beijing Tide Pharmaceutical Co. Ltd. has identified protein arginine N-methyltransferase 5 (PRMT5) inhibitors reported to be useful for the treatment of cancer and myelofibrosis.

Co. Ltd. and Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. have announced IND clearance by China’s National Medical Products Administration (NMPA) for NTB-003 (formerly BCG-009) for thyroid eye ...

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009) ...

Home builders, car manufacturers and can makers are among those that will see higher prices for materials. Those companies ...

Trump and his aides have repeatedly shifted their stance on tariffs in the weeks since the president’s “Liberation Day” ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...